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Evaluation of the presence of selected viral and bacterial nucleic
acids in pericardial samples from dogs with or without idiopathic
pericardial effusion
Abstract
Many viruses have been identified in pericardial fluid and in tissue samples from humans with
pericarditis by means of molecular diagnostics. In canine idiopathic pericardial effusion there is as yet
no conclusive evidence to support the involvement of an infectious agent. This study was designed to
investigate a possible relationship between idiopathic pericardial effusion in dogs and viruses most
commonly encountered in humans affected with viral pericarditis. Coxsackievirus B3 RNA, influenza
virus type A RNA, human adenovirus type 2 DNA, human cytomegalovirus DNA, and parvovirus B19
DNA were investigated using PCR on pericardial effusion samples and pericardial tissue specimens
collected from 14 dogs with idiopathic pericardial effusion. PCR was also used to test for two bacteria,
Borrelia burgdorferi and Chlamydia pneumoniae. The same microorganisms were also looked for in
pericardial effusions or pericardial washes from 10 dogs with neoplastic pericardial effusion, and in
samples collected from 10 dogs which died of a non-cardiac disease. One pericardial effusion sample
from a dog with the idiopathic form of the disease tested positive for influenza virus type A and
sequencing of the amplicon confirmed the PCR result. In another dog from the same group a
cytomegalovirus was detected by PCR in the effusion, but sequencing showed this to be a false-positive
result. The genomes of the microorganisms investigated were not detected in neoplastic effusions or
pericardial washes. The results indicate that viral and bacterial DNA/RNA of relevance for human
pericarditis is rare in pericardial samples from dogs with idiopathic pericardial effusion. The finding of
influenza type A viral RNA in pericardial fluid from one dog with the idiopathic form of the disease
warrants further investigation.
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Abstract 28 
Many viruses have been identified in the pericardial fluid and in tissue samples from 29 
humans with pericarditis by means of molecular diagnostics. In canine idiopathic pericardial 30 
effusion there is yet no conclusive evidence to support the involvement of an infectious agent. 31 
The study was designed to investigate a possible relationship between idiopathic pericardial 32 
effusion in dogs and viruses most commonly encountered in humans affected by viral 33 
pericarditis. Coxsackievirus B3 RNA, influenza virus type A RNA, human adenovirus type 2 34 
DNA, human cytomegalovirus DNA, and parvovirus B19 DNA were investigated by PCR in 35 
pericardial effusion samples and pericardial tissue specimens collected from 14 dogs with a 36 
diagnosis of idiopathic pericardial effusion. PCR was also employed to test the DNA for two 37 
bacteria: Borrelia burgdorferi and Chlamydia pneumoniae. The same microorganisms were 38 
also investigated in pericardial effusion or pericardial wash from 10 dogs with neoplastic 39 
pericardial effusion and 10 dogs which died of a non cardiac disease, respectively. 40 
 41 
One pericardial effusion sample from a dog with the idiopathic form of the disease 42 
tested positive for influenza virus type A and sequencing of the amplicon confirmed the PCR 43 
result. In another dog of the same group a cytomegalovirus was detected by PCR in the 44 
effusion, but sequencing showed this to be a false positive result. The genomes of the 45 
microorganisms investigated were not detected in neoplastic effusions or pericardial washes. 46 
The results indicate that viral and bacterial DNA/RNA of relevance for human pericarditis is 47 
rare in pericardial samples of dogs with idiopathic pericardial effusion. The finding of 48 
influenza type A viral RNA in pericardial fluid from one dog with the idiopathic form of the 49 
disease warrants further investigation. 50 
 51 
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Introduction 53 
Pericardial effusion is the third most common cardiac disease in dogs and accounts for 54 
around 10% of all cardiovascular diseases (Baumgartner and Glaus, 2004). Neoplasia and 55 
idiopathic pericardial effusion (IPE) are the most important aetiologies whereas congestive 56 
heart failure, atrial splitting, trauma, bacterial or fungal pericarditis, uraemia, 57 
peritoneopericardial hernias, intrapericardial cysts, and hypoalbuminemia are rare causes.  58 
 59 
IPE is a diagnosis of exclusion, and is suspected when serosanguinous to hemorrhagic 60 
fluid accumulates in the pericardial space and routine diagnostic methods fail to demonstrate 61 
an underlying cause (Aronsohn and Carpenter, 1999). There is a wide variation in the course 62 
of the disease in IPE; some dogs may be cured after removal of all pericardial effusion by one 63 
single pericardiocentesis, whereas in others effusions may repeatedly recur (Aronsohn and 64 
Carpenter, 1999). 65 
 66 
In human patients, even with exhaustive examinations a specific cause may not be 67 
identified in many cases of IPE although in 20-30% of pericardial effusions viruses have been 68 
identified and considered causative (Zayas et al., 1995; Maisch and Ristic, 2002). In dogs, the 69 
viral hypothesis has been proposed because many cytological reports of the effusions and 70 
histopathological findings of the pericardial sac of dogs affected by IPE present inflammatory 71 
features not indicative of a bacterial, protozoal or fungal infection, and attempts to culture 72 
such microorganisms have been unrewarding (Kienle, 1998). Immunological studies have 73 
been also performed in these dogs and have shown a predominance of IgA positive plasma 74 
cells within inflammatory aggregates in the pericardial tissue (Day and Martin, 2002) and, in 75 
the peripheral blood, a depletion of T lymphocytes with helper cells being mostly affected 76 
(Guglielmino et al., 2004). In a more recent investigation, however, differences were not 77 
detected between immunoglobulin concentrations in peripheral blood and pericardial effusion 78 
in dogs with idiopathic or neoplastic pericardial effusion (Martin et al., 2006). The immune 79 
system appears thus involved in the pathogenesis of the disease, although modestly, but the 80 
aetiology remains unknown. 81 
 82 
There is scarce veterinary literature on viral agents associated with cardiovascular 83 
disease in adult dogs. Molecular genomics have been employed on one occasion to detect 84 
viruses in the myocardium of dogs with active myocarditis and dilated cardiomyopathy. 85 
Among 27 dogs only one dog with dilated cardiomyopathy had amplified canine adenovirus 86 
type 1 (CAV-1) (Maxson et al., 2001). In a second report, West Nile virus was amplified in 87 
the myocardium of a dog showing neurological signs (Buckweitz et al., 2003). To our 88 
knowledge, there are no published data on infectious pericarditis other than rare pyogenic 89 
bacterial infections (Aronson and Gregory, 1995; Stafford Johnson et al., 2003).  90 
 91 
The aim of this retrospective study was to evaluate the potential role of human viruses 92 
in the pathogenesis of canine IPE, by means of polymerase chain reaction (PCR) performed 93 
on samples of pericardial fluid and biopsies of pericardial tissue. Samples were collected from 94 
dogs with a diagnosis of IPE and from dogs with neoplastic pericardial effusion. In addition, a 95 
pericardial wash was collected from dogs which died of a non-cardiac disease. In the light of 96 
the available cooperation between the authors’ affiliations, primers were directed toward the 97 
genome of some of the most important viruses involved in human pericarditis and 98 
myocarditis, including coxsackievirus B3, influenza virus type A, human adenovirus type 2, 99 
human cytomegalovirus and parvovirus B19. Some of them, such as influenza virus type A 100 
and coxsackieviruses have been identified in dogs, but their role as cardiovascular pathogens 101 
has not been investigated in this species (Grew et al., 1970; Kilbourne and Kehoe, 1975). In 102 
addition, common bacterial pathogens of the human cardiovascular system were also included 103 
in the investigation, such as Borrelia burgdorferi and Chlamydia pneumoniae. Recently, C. 104 
pneumoniae has been demonstrated in canine atherosclerotic lesions and B. burgdorferi 105 
myocarditis has been suspected in some dogs (Levy and Duray, 1998; Sako et al., 2002). 106 
Materials and methods 107 
Patients 108 
Between January 2000 and April 2007, samples of pericardial effusion from dogs with 109 
suspected IPE were collected at our institutions. A diagnosis of IPE was made according to 110 
the following criteria: (1) absence of detectable masses within the pericardial space using 111 
echocardiography; (2) absence of pulmonary lesions by thoracic radiography; (3) negative 112 
pericardial fluid cytology for neoplastic disorders; (4) absence of suppurative inflammation of 113 
pericardial fluid cytology or pericardial sac histopathology, or sterile anaerobic/aerobic 114 
bacterial and fungal culture from pericardial effusion; (5) exclusion of underlying metabolic 115 
diseases such as hypoproteinaemia and uraemia by means of a biochemical profile; (6) 116 
exclusion of cardiac diseases causing congestive heart failure and defects of the pericardial 117 
sac (i.e., pericardial cysts) by echocardiography and radiography.  118 
 119 
To increase diagnostic reliability and exclude other potential causes of pericardial 120 
effusion (e.g. neoplasia) the animals needed a follow-up of at least 12 months during which 121 
they did not develop any other disease. Pericardial effusions due to primary or secondary 122 
neoplastic infiltration of the pericardium or heart were also stored. In addition, pericardial 123 
fluid obtained through pericardial wash was collected from dogs which died of a non cardiac 124 
disease. The two last groups served as control. 125 
 126 
Sample collection 127 
Pericardial effusions were collected in all dogs by echocardiography guided 128 
pericardiocentesis. To avoid any contamination, routine aseptic techniques were used for 129 
preparation of the thoracic area. The pericardial effusion was collected by the operator 130 
wearing sterile gloves and rapidly placed into a sterile vacuum tube. Pericardial tissue 131 
fragments were collected under thoracoscopy in order to minimize pericardial sac handling 132 
and contamination. In dogs which died due to a non cardiac disease a pericardial wash was 133 
collected within 3 h from death. After thoracotomy the pericardial sac was identified and 134 
injected with 15-20 mL of sterile saline using a 21-G needle. After 5-10 s the fluid was 135 
removed through the same needle. Care was provided in order to prevent contamination as 136 
above. Effusion samples and pericardial tissue fragments were stored at -70 °C until 137 
examination. 138 
 139 
Polymerase chain reaction (PCR) 140 
Conventional PCR was used to investigate pericardial effusion or wash samples and 141 
pericardial tissue fragments of dogs. Pericardial fluids and pericardial biopsies were 142 
investigated for the presence of Coxsackievirus B3 RNA, influenza virus type A RNA, human 143 
cytomegalovirus DNA, parvovirus B19 DNA and human adenovirus type 2 DNA (Table 1). 144 
Primer pairs were also used to test for the presence of B. burgdorferi and C. pneumoniae 145 
DNA. At the laboratory of two of the authors (SP, BM), primers for these two bacteria are 146 
normally part of the investigative panel of human patients with pericarditis or myocarditis. 147 
 148 
To extract RNA/DNA from pericardial fluids and pericardial biopsies, the QIAamp 149 
Viral Mini Kit and the QIAamp Tissue Kit (Qiagen) were used. To avoid false-positive 150 
results, extraction amplification and electrophoresis were performed in separate areas and in 151 
duplicates. Also, a water sample was extracted as well, as a negative control. Ten microlitres 152 
of extracted RNA/DNA were incubated with 25 pmol of the appropriate primer, 5 µL 10x 153 
PCR buffer (1.5 mmol MgCl2), 10 mmol dNTPs, and 2.5 U Taq polymerase gold (Applied 154 
Biosystems) and deionised H2O in a 50 µL final reaction volume. After an initial incubation at 155 
94 °C for 12 min, 40 rounds of amplification were performed under the following conditions: 156 
94 °C (denaturation) for 45 s, appropriate temperature for each primer pair for 45 s (Table 1), 157 
72 °C (extension) for 1 min. A final cycle of 72 °C for 5 min for complete polymerisation 158 
followed. For detection of the RNA-viruses (influenza virus A and coxsackievirus B3) an 159 
initial reverse transcription using the RT-One-step-PCR-KIT (Qiagen) was performed. Two 160 
negative controls (sterile distilled water) and three serial dilutions of positive control were 161 
included in every PCR assay. Beta-actin was used as internal control for PCR (data not 162 
shown). Ten microlitres of each reaction were analysed on a 1.5% agarose gel (Sigma) 163 
containing 0.5 µg/mL ethidium bromide. For the control of size, basepair marker No. VIII 164 
ranging from 37-1114 basepairs (Boehringer Mannheim) was used. Primer sensitivity was 165 
determined for each pair by our laboratory (Table 2). Specificity was assessed in silico for all 166 
primer pairs through a GenBank database search and, apart the target genes, other sequences 167 
could not be identified. 168 
 169 
Sequencing 170 
To obtain enough material to be sequenced, influenza A and cytomegalovirus positive 171 
samples were reamplified using the same PCR conditions as described above using 2 µL of 172 
the previous PCR reaction. Products were analyzed on 3% agarose gels; amplicons were 173 
purified using the MinElute Gel Extraction Kit (Qiagen) and sequenced from both sides 174 
(Microsynth). 175 
 176 
Results 177 
Thirty-four dogs were enrolled in the study. Fourteen dogs had a diagnosis of IPE, 10 178 
a diagnosis of pericardial or heart neoplasia and 10 had a non cardiac disease. Among dogs 179 
with neoplastic effusion, five had pericardial mesothelioma, three heart haemangiosarcoma, 180 
and one each a pericardial carcinoma or an unclassified metastatic neoplasia. Six dogs which 181 
died of a non cardiac disease had metastatic tumours and two each end-stage renal or liver 182 
failure. 183 
 184 
In the group of dogs with IPE, 11 were males and 3 were females. Ten dogs belonged 185 
to large or giant breeds and four belonged to medium-size breeds. The age ranged from 3-13 186 
years, with a median age of 8 years. In nine dogs pericardial effusion was collected during the 187 
first episode of IPE, in five others IPE was already diagnosed and they were referred when 188 
many relapses had occurred (three relapses in four dogs and four relapses in one dog) and 189 
thoracoscopic fenestration of the pericardial sac was required.  190 
 191 
During the 12-month follow-up period, one dog had a single recurrence of pericardial 192 
effusion requiring removal of the pericardial fluid and another had two relapses. In the group 193 
of dogs with neoplastic effusion, 6 were males and 4 females. Six dogs belonged to large or 194 
giant breeds and the remaining to medium or small-size breeds. The age ranged from 5-14 195 
years, with a median age of 10 years. In the group of dogs with non cardiac disease, 5 were 196 
males and 5 females. Five dogs belonged to large or giant breed and five to small-size breeds. 197 
The age ranged from 7-14 years, with a median age of 11 years. 198 
 199 
In dogs with neoplastic effusion or non-cardiac disease a single effusion sample or 200 
pericardial wash was submitted for the viral and bacterial screening, respectively. With PCR 201 
none of the samples tested positive for the investigated microorganisms. In dogs with IPE a 202 
total of 11 effusion samples and of five pericardial biopsies were analysed. Nine dogs had 203 
only the pericardial effusion investigated, two had investigated both the pericardial effusion 204 
and the pericardial tissue, and three the pericardial tissue only. In the pericardial fluid samples 205 
positive results were obtained for influenza virus type A (Fig. 1) and for human 206 
cytomegalovirus in one dog each. In each of these dogs both duplicates examined were 207 
positive. Samples of both dogs were collected during the first episode of pericardial effusion.  208 
 209 
Definitive confirmation by genomic sequencing was successfully obtained only in the 210 
case of influenza virus type A (GenBank accession No: AY920454). The sequenced 229 bp-211 
long segment of the matrix protein (M1) showed 96-100% homology with the first 100 212 
sequences gathered from GenBank; the homology was always with an influenza virus type A 213 
(several subtypes). In the case of cytomegalovirus the sequence obtained was not consistent 214 
with the target product and did not show any homologies with published sequences; thus the 215 
amplicon was not cytomegalovirus. None of the pericardial tissue fragments or pericardial 216 
effusions was positive for coxsackievirus B3, parvovirus B19 and human adenovirus type 2. 217 
B. burgdorferi or C. pneumoniae were not detected in any dog with IPE. 218 
 219 
Discussion 220 
To the best of our knowledge, so far no study has yet been performed to investigate 221 
viruses as possible agents involved in the development of IPE in dogs. This is the first report 222 
to show that one of the viruses involved in human infectious pericarditis could also be 223 
recognised in a dog affected by IPE. Specifically, we were able to detect and sequence part of 224 
the genome of influenza type A in 1/14 dogs with IPE and in none of the dogs with neoplastic 225 
effusions or in pericardial washes from dogs without cardiovascular disease.  226 
 227 
Influenza viruses type A, as well as types B and C, can cause infections in dogs both 228 
naturally and experimentally (Todd and Cohen, 1968; Nikitin et al., 1972; Kilbourne and 229 
Kehoe, 1975; Manuguerra and Hannoun, 1992), however current data suggest influenza 230 
viruses in dogs to cause only mild disease, whereas cardiovascular disorders have not yet 231 
been described or investigated. 232 
 233 
During the last decade an increasing number of viruses have been identified in the 234 
pericardial fluid and tissue from affected humans, and viral pericarditis is now an established 235 
cause of pericardial effusion in this species (Zayas et al., 1995). Although in humans 236 
influenza viruses type A are implicated as cause of pericarditis, these viruses are more 237 
commonly associated with myocarditis, and when pericardial effusion occurs, it is mainly 238 
observed in conjunction with myocarditis (Engblom et al., 1983; Proby et al., 1986; 239 
Pankuweit et al., 2000). In our dog where the viral genome was sequenced, isolation was 240 
coincident with the diagnosis of IPE and, in contrast to human patients, the pericardial 241 
participation was apparently isolated, without concomitant involvement of the myocardium. It 242 
must be noted, that without histopathology the possibility of a focal transitory and subclinical 243 
myocarditis cannot be definitely excluded. However, the blood biochemical panel did not 244 
include markers of myocardial damage such as creatine-kinase or troponins, but 245 
echocardiographic evaluation after pericardiocentesis did not identify any systolic 246 
dysfunction, diskynesia or focal myocardial lesion, suggestive of a significant myocardial 247 
damage. 248 
 249 
Although the influenza virus type A genome was not identified in dogs with neoplastic 250 
effusions or in pericardial washes of dogs without cardiovascular disease, it is important to 251 
emphasize that the identification of the viral RNA in a dog with IPE may not represent the 252 
explanation for the pericardial disorder. Even if influenza viruses are commonly associated 253 
with pericarditis in humans, and even if dogs may be infected with these viruses, finding the 254 
viral genome does not prove a causative role of these pathogens. It may actually be possible 255 
that the dog organism behaved like a passive bystander without replication in cardiac tissue. 256 
The virus could have been acquired by the close proximity with the owner; in fact, exposure 257 
of dogs to influenza virus as assessed by seroconversion has been demonstrated after human 258 
pandemics (Todd and Cohen, 1968; Nikitin et al., 1972). Even though further characterization 259 
of the viral subtype (i.e., haemagglutinins, neuraminidase) has not been attempted, according 260 
to currently published gene sequences, the human and very rarely the pig and camel are the 261 
only species where the influenza virus type A expressing the sequenced matrix protein (M1) 262 
is found. Based on the dog’s clinical history, contact with pigs and camels is excluded, and 263 
the hypothesised viral transmission from human to dog seems most probable. 264 
 265 
Finally, it is important to note that the sensitivity of the PCR protocol used in the 266 
present investigation may not have been high enough to detect very low concentrations of 267 
viral or bacterial gene copies. Also, the sensitivity could have been negatively influenced by 268 
the detection of pathogen variants, common in particular for some viruses, such as influenza 269 
viruses. Both factors may have underemphasised the strength of our results. It is also possible 270 
that the identification of the viral genome could have been merely due to contamination of the 271 
pericardial effusion during sample handling. In the authors’ opinion, however, this possibility 272 
seems less likely as collection of the pericardial fluid was achieved in aseptic conditions and 273 
then, through the laboratory procedures, the sample was examined in duplicate. 274 
 275 
Conclusions 276 
The finding of human influenza virus in a dog supports the concept that viral 277 
pericarditis may be a cause of IPE also in dogs. However, a cause-and-effect relationship is 278 
not proven by the identification of one human virus in one dog with the disease, and further 279 
studies including canine pathogens and different strains are thus needed to elucidate the role 280 
of infectious organisms in canine IPE. 281 
 282 
Acknowledgments 283 
We are especially grateful to Dr. P. Ossent, H. Eckhardt and D. Strache for their 284 
indispensable assistance to collect canine samples and perform PCR. We also thank the 285 
technicians of the clinical laboratory under the supervision of E. Rogg for their excellent 286 
technical support. 287 
 288 
References 289 
 290 
Aronsohn, M.G., Carpenter, J.L., 1999. Surgical treatment of idiopathic pericardial effusion in 291 
the dog: 25 cases (1978-1993). Journal of the American Animal Hospital Association 35, 292 
521-525. 293 
Aronson, L.R., Gregory, C.R., 1995. Infectious pericardial effusion in five dogs. Veterinary 294 
Surgery 24, 402-407. 295 
Baumgartner, C., Glaus, T.M., 2004. Acquired cardiac diseases in the dog: a retrospective 296 
analysis. Schweizer Archiv fur Tierheilkunde 146, 423-430. 297 
Buckweitz, S., Kleiboeker, S., Marioni, K., Ramos-Vara, J., Rottinghaus, A., Schwabenton, 298 
B., Johnson, G., 2003. Serological, reverse transcriptase-polymerase chain reaction, and 299 
immunohistochemical detection of West Nile virus in a clinically affected dog. Journal of 300 
Veterinary Diagnostic Investigation 15, 324-329. 301 
Day, M.J., Martin, M.W.S., 2002. Immunohistochemical characterization of the lesions of 302 
canine idiopathic pericarditis. Journal of Small Animal Practice 43, 382-387. 303 
Engblom, E., Ekfors, T.O., Meurman, O.H., Toivanen, A., Nikoskelainen, J., 1983. Fatal 304 
influenza A myocarditis with isolation of virus from myocardium. Acta Medica 305 
Scandinavica 213, 75-78. 306 
Grew, N., Gohd, R.S., Arguedas, J., Kato, J.I., 1970. Enteroviruses in rural families and their 307 
domestic animals. American Journal of Epidemiology 91, 518-526. 308 
Guglielmino, R., Miniscalco, B., Tarducci, A., Borgarelli, M., Riondato, F., Zini, E., Borrelli, 309 
A., Bussadori, C., 2004. Blood lymphocyte subsets in canine idiopathic pericardial 310 
effusion. Veterinary Immunology and Immunopathology 98, 167-173. 311 
Kienle, R.D., 1998. Pericardial disease and cardiac neoplasia. In: Kittleson, M.D., Kienle, 312 
R.D. (Eds.), Small animal cardiovascular medicine, Mosby Inc., St. Louis, MO, pp. 413-313 
432. 314 
Kilbourne, E.D., Kehoe, J.M., 1975. Demonstration of antibodies to both hemagglutinin and 315 
neuraminidase antigens of H3N2 influenza A virus in domestic dogs. Intervirology 6, 315-316 
318. 317 
Levy, S.A., Duray, P.H., 1988. Complete heart block in a dog seropositive for Borrelia 318 
burgdorferi. Similarity to human Lyme carditis. Journal of Veterinary Internal Medicine 319 
2, 138-144. 320 
Maisch, B., Ristic, A.D., 2002. The classification of pericardial disease in the age of modern 321 
medicine. Current Cardiology Reports 4, 13-21. 322 
Manuguerra, J.C., Hannoun, C., 1992. Natural infection of dogs by influenza C virus. 323 
Research in Virology 143, 199-204. 324 
Martin, M.W., Green, M.J., Stafford Johnson, M.J., Day, M.J., 2006. Idiopathic pericarditis in 325 
dogs: no evidence for an immune-mediated aetiology. Journal of Small Animal Practice 326 
47, 387-391. 327 
Maxson, T.R., Meurs, K.M., Lehmkuhl, L.B., Magnon, A.L., Weisbrode, S.E., Atkins, C.E., 328 
2001. Polymerase chain reaction analysis for viruses in paraffin-embedded myocardium 329 
from dogs with dilated cardiomyopathy or myocarditis. American Journal of Veterinary 330 
Research 62, 130-135. 331 
Nikitin, A., Cohen, D., Todd, J.D., Lief, F.S., 1972. Epidemiological studies of A/Hong 332 
Kong/68 virus infection in dogs. Bulletin of the World Health Organization 47, 471-479. 333 
Pankuweit, S., Wadlich, A., Meyer, E., Portig, I., Hufnagel, G., Maisch, B., 2000. Cytokine 334 
activation in pericardial fluids in different forms of pericarditis. Herz 25, 748-754. 335 
Proby, C.M., Hackett, D., Gupta, S., Cox, T.M., 1986. Acute myopericarditis in influenza A 336 
infection. The Quarterly Journal of Medicine 233, 887-892. 337 
Sako, T., Takahashi, T., Takehana, K., Uchida, E., Nakade, T., Umemura, T., Taniyama, H., 338 
2002. Chalmydial infection in canine atherosclerotic lesions. Atherosclerosis 162, 253-339 
259. 340 
Stafford Johnson, J.M., Martin, M.W., Stidworthy, M.F., 2003. Septic fibrinous pericarditis in 341 
a cocker spaniel. Journal of Small Animal Practice 44, 117-120. 342 
Todd, J.D., Cohen, D., 1968. Studies of influenza in dogs. I. Susceptibility of dogs to natural 343 
and experimental infection with human A2 and B strains of influenza virus. American 344 
Journal of Epidemiology 87, 426-439. 345 
Zayas, R., Anguita, M., Torres, F., Gimenez, D., Bergillos, F., Ruiz, M., Ciudad, M., 346 
Gallardo, A., Valles, F., 1995. Incidence of specific etiology and role of methods for 347 
specific etiologic diagnosis of primary acute pericarditis. American Journal of Cardiology 348 
75, 378-382. 349 
 350 
 Table 1. Primer pairs used for sequence detection in this study. 351 
 352 
Pathogen Target gene Primer Sequence (5’-3’) Annealing temperature (°C)
Length of the PCR 
product (bp) 
NCBI accession 
number 
Coxsackievirus 
B3 5' UTR 
Forward 
Reverse 
TCCGGCCCCTGAATG 
CACCGGATGGCCAATCCA 60 195 M74567 
Influenza virus 
type A 
Matrix 
protein M1 
Forward 
Reverse 
CAGATTGCTGACTCCCAGCA 
GACCAGCACTGGAGCTAGGATGA 67 229 J02145 
Human 
adenovirus type 2 Hexon 
Forward 
Reverse 
GCCGCAGTGGTCTTACATGCACATC 
CAGCACGCCGCGGATGTCAAAGT 68 301 J01917 
Human 
cytomegalovirus US10/11 
Forward 
Reverse 
GTTCTCTCGTCTCCTCCGTG 
CCTGTGGAGCTCGTTAGAGG 57 362 AY446894 
parvovirus B19 ORF2 (VP1) Forward Reverse 
GATACTCAACCCCATGGAGA 
GCCCTAACACATATGGGTACTT 59 249 AF264149 
B. burgdorferi 16S rRNA Forward Reverse 
ACACTGGAACTGAGATACGGT 
ATTCCACCCTTACACCAGA 61 386 X85195 
C. pneumoniae 
Major outer 
membrane 
protein 
Forward 
Reverse 
CTTGCCTGTAGGGAACCCTT 
CTTTAAGATACGGTCGAAAACATAG 54 160 L04982 
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 Table 2. Sensitivity of PCR primers. 355 
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Pathogen 
Primer 
sensitivity 
(genome copies) 
Isolates used for 
determination of 
sensitivity 
 
NCBI accession 
number. 
Coxsackievirus B 3 50 coxsackievirus B3 (strain Woodruff) M74567 
Influenza virus type A 50 influenza A (strain PR8) J02145 
Human adenovirus 
type 2 50 
Human adenovirus 
(strain ADV type 6) DQ149613 
Human 
cytomegalovirus 100 
Human cytomegalovirus 
(strain AD169) C17403 
Parvovirus B19 50 Human serum (human PVB19 pos) M50517 
B. burgdorferi 100 B. burgdorferi (strain B 29) X85195 
C. pneumoniae 100 C. pneumoniae (strain TWAR ) L04982 
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